These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 955131

  • 1. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M, Morris SE, Groom GV, Jenner DA, Scarisbrick JJ, Cameron EH.
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 3. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov 15; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Jul 01; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 6. Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission.
    Morris SE, Groom GV, Cameron ED, Buckingham MS, Everitt JM, Elstein M.
    Contraception; 1979 Jul 01; 20(1):61-9. PubMed ID: 477318
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA, Brenner PF, Kletzky OA, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
    [Abstract] [Full Text] [Related]

  • 8. New combined oral contraceptive with incremental progestogen dosage regimen.
    Brosens I, Van Assche A, Koninckx P, Heyns W, De Hertogh R.
    Eur J Obstet Gynecol Reprod Biol; 1976 Apr 01; 6(6):315-8. PubMed ID: 1035172
    [Abstract] [Full Text] [Related]

  • 9. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
    Ryu K, Yu HK, Kwak HM, Hong SS.
    Contraception; 1983 Mar 01; 27(3):299-310. PubMed ID: 6406140
    [Abstract] [Full Text] [Related]

  • 10. Comparison of plasma hormone changes using a "conventional" and a "paper" pill formulation of a low-dose oral contraceptive.
    Morris SE, Scarisbrick JJ, Cameron EH, Groom GV, Buckingham MS, Everitt J, Elstein M.
    Fertil Steril; 1978 Mar 01; 29(3):296-303. PubMed ID: 640048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA, Moghissi KS, Borin K.
    Fertil Steril; 1981 Mar 16; 35(3):284-8. PubMed ID: 6781938
    [Abstract] [Full Text] [Related]

  • 16. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A, Ditrói F, Lampé LG.
    Acta Univ Palacki Olomuc Fac Med; 1981 Mar 16; 101():95-101. PubMed ID: 6242699
    [Abstract] [Full Text] [Related]

  • 17. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1981 Aug 16; 24(2):159-72. PubMed ID: 6794980
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC.
    J Clin Endocrinol Metab; 1979 Sep 16; 49(3):346-9. PubMed ID: 224073
    [Abstract] [Full Text] [Related]

  • 19. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
    Ryu K, Hong SS.
    Contraception; 1983 Jun 16; 27(6):605-17. PubMed ID: 6413131
    [Abstract] [Full Text] [Related]

  • 20. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug 16; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.